Ekso Bionics Holdings Inc (EKSO) concluded trading on Thursday at a closing price of $0.40, with 98.43 million shares of worth about $39.37 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -48.32% during that period and on May 15, 2025 the price saw a loss of about -11.50%. Currently the company’s common shares owned by public are about 28.20M shares, out of which, 27.09M shares are available for trading.
Stock saw a price change of -3.24% in past 5 days and over the past one month there was a price change of 0.73%. Year-to-date (YTD), EKSO shares are showing a performance of -34.43% which decreased to -71.01% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.34 but also hit the highest price of $1.53 during that period. The average intraday trading volume for Ekso Bionics Holdings Inc shares is 198.00K. The stock is currently trading -9.84% below its 20-day simple moving average (SMA20), while that difference is down -6.12% for SMA50 and it goes to -45.65% lower than SMA200.
Ekso Bionics Holdings Inc (NASDAQ: EKSO) currently have 28.20M outstanding shares and institutions hold larger chunk of about 14.38% of that.
The stock has a current market capitalization of $11.62M and its 3Y-monthly beta is at 1.07. It has posted earnings per share of -$0.49 in the same period. It has Quick Ratio of 1.77 while making debt-to-equity ratio of 0.44. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EKSO, volatility over the week remained 24.57% while standing at 13.31% over the month.
Stock’s fiscal year EPS is expected to rise by 35.71% while it is estimated to increase by 34.72% in next year. EPS is likely to grow at an annualized rate of 41.87% for next 5-years, compared to annual growth of 25.99% made by the stock over the past 5-years.
